Takeda Pharmaceutical (TAK) Goodwill (2017 - 2026)

Takeda Pharmaceutical's Goodwill history runs 10 years deep, the most recent figure standing at $37.0 billion for Q1 2026.

• On a quarterly basis, Goodwill rose 6.14% year-over-year to $37.0 billion in Q1 2026; TTM through Mar 2026 was $37.0 billion, a 6.14% increase from a year earlier, with the FY2026 full-year figure at $38.6 billion, up 10.4% from the prior year.
• Goodwill slipped to $37.0 billion in Q1 2026 per TAK's latest filing, from $37.4 billion in the prior quarter.
• Across five years, Goodwill topped out at $37.9 billion in Q1 2022 and bottomed at $33.2 billion in Q4 2022.
• The 5-year median for Goodwill is $36.6 billion (2025), against an average of $36.3 billion.
• Across the five-year window, Goodwill slipped 9.44% in 2022 and climbed 6.56% in 2025, its largest moves.
• Year by year, Goodwill stood at $33.2 billion in 2022, then gained by 4.14% to $34.6 billion in 2023, then climbed by 5.04% to $36.3 billion in 2024, then increased by 2.92% to $37.4 billion in 2025, then retreated by 0.92% to $37.0 billion in 2026.
• Per Business Quant, the three latest TAK Goodwill figures stand at $37.0 billion (Q1 2026), $37.4 billion (Q4 2025), and $36.9 billion (Q3 2025).